NO20071221L - Systemer og fremgangsmater for protein produksjon. - Google Patents

Systemer og fremgangsmater for protein produksjon.

Info

Publication number
NO20071221L
NO20071221L NO20071221A NO20071221A NO20071221L NO 20071221 L NO20071221 L NO 20071221L NO 20071221 A NO20071221 A NO 20071221A NO 20071221 A NO20071221 A NO 20071221A NO 20071221 L NO20071221 L NO 20071221L
Authority
NO
Norway
Prior art keywords
cells
protein
interest
systems
polypeptide
Prior art date
Application number
NO20071221A
Other languages
English (en)
Norwegian (no)
Inventor
Yijie Gao
Nicole M Piche
Mei Geng
Stephen H Herrmann
Xiaotian Zhong
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of NO20071221L publication Critical patent/NO20071221L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20071221A 2004-09-02 2007-03-06 Systemer og fremgangsmater for protein produksjon. NO20071221L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60643904P 2004-09-02 2004-09-02
PCT/US2005/031081 WO2006028889A2 (en) 2004-09-02 2005-09-01 Systems and methods for protein production

Publications (1)

Publication Number Publication Date
NO20071221L true NO20071221L (no) 2007-03-30

Family

ID=36036848

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20071221A NO20071221L (no) 2004-09-02 2007-03-06 Systemer og fremgangsmater for protein produksjon.

Country Status (16)

Country Link
US (3) US7514237B2 (pt)
EP (2) EP1784490B1 (pt)
JP (2) JP2008511335A (pt)
KR (1) KR20070053732A (pt)
CN (1) CN101048509A (pt)
AU (1) AU2005282746A1 (pt)
BR (1) BRPI0514870A (pt)
CA (1) CA2577073C (pt)
CR (1) CR8927A (pt)
EC (1) ECSP077295A (pt)
ES (2) ES2653843T3 (pt)
IL (1) IL181278A0 (pt)
MX (1) MX2007002379A (pt)
NO (1) NO20071221L (pt)
RU (1) RU2007106442A (pt)
WO (1) WO2006028889A2 (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5548932B2 (ja) * 2006-09-25 2014-07-16 国立大学法人大阪大学 Ａｔｆ４および／またはｇａｄｄ３４を利用した蛋白質高生産方法
CA2726289A1 (en) * 2008-05-28 2009-12-23 Bayer Healthcare Llc Methods and compositions for production of recombinant protein in hbx-expressing mammalian cells
WO2009149021A2 (en) 2008-06-02 2009-12-10 Dana-Farber Cancer Institute, Inc. Xbp1, cd138, and cs1 peptides
US9315565B2 (en) 2009-02-10 2016-04-19 Ucb Pharma, S.A. Method for producing protein
GB0902180D0 (en) * 2009-02-10 2009-03-25 Ucb Pharma Sa Method for producing protein
WO2010151827A1 (en) * 2009-06-25 2010-12-29 Bayer Healthcare Llc X-box binding proteins (xbp-1) variants and methods of using the same
TW201823460A (zh) 2012-05-29 2018-07-01 美商再生元醫藥公司 生產細胞株增強子
CL2015003242A1 (es) * 2015-11-04 2016-10-14 Univ Chile Virus aav/upr-plus, proteína de fusión upr-plus, método de tratamiento genético y su uso en el tratamiento enfermedades neurodegenerativas, tales como las enfermedades de parkinson y huntington, entre otras.
WO2019010551A1 (pt) * 2017-07-10 2019-01-17 Instituto De Biologia Molecular Do Paraná - Ibmp Plataforma genética para superexpressão heteróloga associada à seleção de células altamente produtoras de proteínas
CN107858378B (zh) * 2017-11-20 2020-11-10 中国科学院生物物理研究所 衰老细胞模型及其制备方法
CN110093361B (zh) * 2019-04-17 2023-05-09 拜澳泰克(沈阳)生物医学集团有限公司 一种增强基因表达的增强子多肽及其应用
WO2022067214A2 (en) 2020-09-28 2022-03-31 Vestaron Corporation Mu-diguetoxin-dc1a variant polypeptides for pest control
WO2022136140A1 (en) * 2020-12-22 2022-06-30 F. Hoffmann-La Roche Ag Oligonucleotides targeting xbp1
WO2022235929A1 (en) 2021-05-05 2022-11-10 Radius Pharmaceuticals, Inc. Animal model having homologous recombination of mouse pth1 receptor
WO2023122805A1 (en) 2021-12-20 2023-06-29 Vestaron Corporation Sorbitol driven selection pressure method
CA3256326A1 (en) 2022-06-09 2023-12-14 CHO Plus Inc. CELL HYBRIDS AS HOST CELLS FOR HIGH-YIELD PRODUCTION OF GENE THERAPY VECTORS AND VIRAL VACCINES
WO2024026406A2 (en) 2022-07-29 2024-02-01 Vestaron Corporation Next Generation ACTX Peptides
WO2025024776A2 (en) * 2023-07-27 2025-01-30 Duke University Compositions comprising xbp1 fragments and methods of use in gene therapy
WO2026015884A1 (en) * 2024-07-11 2026-01-15 Helix Nanotechnologies Inc Compositions comprising ire-1 binding sequences and uses thereof
CN120888609B (zh) * 2025-10-10 2025-12-23 汇智和源生物技术(苏州)有限公司 一种瞬时高效表达人源slc转运体oatp1b3的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6063630A (en) 1991-11-05 2000-05-16 Transkaryotic Therapies, Inc. Targeted introduction of DNA into primary or secondary cells and their use for gene therapy
ES2256972T3 (es) 1997-11-18 2006-07-16 Pioneer Hi-Bred International, Inc. Metodo novedoso para la integracion de un adn foraneo dentro de genomas de eucariotas.
WO2000001835A2 (en) 1998-07-01 2000-01-13 Austrian Nordic Biotherapeutics Ag Targeted integration into chromosomes using retroviral vectors
JP2001054391A (ja) * 1998-11-13 2001-02-27 Hsp Kenkyusho:Kk 小胞体ストレス転写因子
CA2403842C (en) 2000-03-24 2012-09-25 Genencor International, Inc. Increased production of secreted proteins by recombinant eukaryotic cells
WO2003089622A2 (en) * 2002-04-22 2003-10-30 University Of Michigan Novel genes, compositions, and methods for modulating the unfolded protein response
JP4446057B2 (ja) * 2002-08-28 2010-04-07 独立行政法人理化学研究所 生体刺激存在下でのｍＲＮＡのフレームシフトを利用した蛋白質の発現方法
US20050106222A1 (en) * 2003-06-11 2005-05-19 Ailor Eric N. Method to increase protein production in culture

Also Published As

Publication number Publication date
US20120322104A1 (en) 2012-12-20
KR20070053732A (ko) 2007-05-25
CR8927A (es) 2007-08-28
AU2005282746A1 (en) 2006-03-16
US7514237B2 (en) 2009-04-07
RU2007106442A (ru) 2008-10-10
US20090221035A1 (en) 2009-09-03
EP1784490A2 (en) 2007-05-16
US8173394B2 (en) 2012-05-08
ES2649862T3 (es) 2018-01-16
CA2577073A1 (en) 2006-03-16
ES2653843T3 (es) 2018-02-09
IL181278A0 (en) 2007-07-04
EP1784490B1 (en) 2017-11-01
JP5508460B2 (ja) 2014-05-28
EP2316955A1 (en) 2011-05-04
BRPI0514870A (pt) 2008-06-24
US20060053502A1 (en) 2006-03-09
EP2316955B1 (en) 2017-10-04
MX2007002379A (es) 2007-04-23
WO2006028889A3 (en) 2006-10-05
CA2577073C (en) 2016-10-11
ECSP077295A (es) 2007-04-26
JP2008511335A (ja) 2008-04-17
CN101048509A (zh) 2007-10-03
WO2006028889A2 (en) 2006-03-16
JP2012161318A (ja) 2012-08-30

Similar Documents

Publication Publication Date Title
NO20071221L (no) Systemer og fremgangsmater for protein produksjon.
Madio et al. Sea anemone toxins: A structural overview
Hirano et al. Design and synthesis of a homogeneous erythropoietin analogue with two human complex‐type sialyloligosaccharides: combined use of chemical and bacterial protein expression methods
Frazão et al. Sea anemone (Cnidaria, Anthozoa, Actiniaria) toxins: an overview
Loos et al. Expression and glycoengineering of functionally active heteromultimeric IgM in plants
Fan et al. Spent hen protein hydrolysate with good gastrointestinal stability and permeability in caco-2 cells shows antihypertensive activity in SHR
Fry et al. Tentacles of venom: toxic protein convergence in the Kingdom Animalia
Nwachukwu et al. Thermoase-derived flaxseed protein hydrolysates and membrane ultrafiltration peptide fractions have systolic blood pressure-lowering effects in spontaneously hypertensive rats
Yee et al. Snake venom metalloproteinases and their peptide inhibitors from Myanmar Russell’s viper venom
DK1423419T3 (da) Hybrid- og tandemekspression af Neisseria-proteiner
Rheault et al. Molecular cloning, phylogeny and localization of AgNHA1: the first Na+/H+ antiporter (NHA) from a metazoan, Anopheles gambiae
Martínez-Alarcón et al. Expression of lectins in heterologous systems
Tan et al. Tenebrio molitor proteins-derived DPP-4 inhibitory peptides: Preparation, identification, and molecular binding mechanism
BR0107474A (pt) Preparação de proteìnas e permuteìnas desalergenizadas
ATE472333T1 (de) Rückfaltung von proteinen der transforming-growth-factor-beta-familie
NO872932L (no) Fremgangsmaate for fremstilling av proteiner med faktorviiiaktivitet ved hjelp av mikrobielle vertsceller, eksprimeringsvektorer, vertsceller, antibiotika.
Hayes et al. Generation of bioactive peptides from Porphyridium sp. and assessment of their potential for use in the prevention of hypertension, inflammation and pain
Samtiya et al. Production, purification, and potential health applications of edible seeds’ bioactive peptides: A concise review
Sarkar et al. Evaluation of anti-oxinflammatory and ACE-inhibitory properties of protein hydrolysates obtained from edible non-mulberry silkworm pupae (Antheraea assama and Philosomia ricinii)
Hayes et al. Identification of bioactive peptides from Nannochloropsis oculata using a combination of enzymatic treatment, in silico analysis and chemical synthesis
Walker et al. Missiles of mass disruption: composition and glandular origin of venom used as a projectile defensive weapon by the assassin bug Platymeris rhadamanthus
Monastyrnaya et al. The sea anemone neurotoxins modulating sodium channels: an insight at structure and functional activity after four decades of investigation
Pérez-Polo et al. Identifying natural bioactive peptides from the common octopus (Octopus vulgaris Cuvier, 1797) skin mucus by-products using proteogenomic analysis
Ventura et al. Glycoproteins involved in sea urchin temporary adhesion
Ayala-Niño et al. Novel bioactive peptides sequences released by in vitro digestion of proteins isolated from Amaranthus hypochondriacus

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application